Delivery Order SPE2DB24D2010-SPE2DB24FZVK9
Award Date
6/21/24
Potential Completion Date
7/15/24
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Department of Defense (DoD) and its Medical Supply Chain agency. The ceiling value of the firm-fixed-price delivery order is $51,841.24, with a period of performance through June 20, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the Defense...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division provides for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $51,841.24 firm fixed price delivery order contract has a completion date of June 6, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC,...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The $25,920.62 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of September 26, 2024. This contract is not set aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,920.62 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The $69,234.85 firm fixed-price delivery order contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025 and was awarded on June 25, 2025. It is not designated as a set-aside contract, indicating open...
The U.S. Department of Defense's Medical Supply Chain (DLA Troop Support Medical) awarded a delivery order contract valued at $12,960.30 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order worth $49,381.36 to provide VYNDAMAX 61 MG CAPSULE UD 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the DLA with a potential value of $999,999,999.00 and a performance period through December 31,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,816.48, is a delivery order for VYNDAMAX 61 MG CAPSULE UD 30S. It is a firm fixed-price contract with an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, with an ultimate completion date of August 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of the drug VYNDAMAX 61 MG CAPSULE UD 30S, with a ceiling value of $25,920.62 and an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...